This HTML5 document contains 37 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n11http://linked.opendata.cz/resource/drugbank/drug/DB01496/identifier/pubchem-compound/
n13http://linked.opendata.cz/resource/drugbank/drug/DB01496/identifier/pubchem-substance/
n9http://linked.opendata.cz/resource/drugbank/drug/DB01496/identifier/drugbank/
n6http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n10http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n8http://linked.opendata.cz/resource/drugbank/drug/DB01496/identifier/chemspider/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB01496
rdf:type
n3:Drug
n3:group
illicit experimental
owl:sameAs
n6:DB01496 n10:DB01496
dcterms:title
Barbituric acid derivative
adms:identifier
n8:2273815 n9:DB01496 n11:3003157 n13:46507405
n3:synthesisReference
Akinori Fujita, "Phenylurethane compounds and methods for producing same, asymmetric urea compounds and methods for producing same, barbituric acid derivative, and diazo thermal recording material containing the derivative." U.S. Patent US20020161225, issued October 31, 2002.
n3:IUPAC-Name
n4:271B4FF4-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4FFA-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4FF9-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4FF6-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4FF7-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4FF8-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4FF2-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4FF0-363D-11E5-9242-09173F13E4C5 n4:271B4FF3-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4FF1-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B5000-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B5001-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4FFB-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4FFC-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4FFE-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4FFD-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4FFF-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B5006-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B5008-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B5009-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B5005-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B5004-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B5007-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4FF5-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B5002-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B5003-363D-11E5-9242-09173F13E4C5